Oklo (NYSE:OKLO) Receives Buy Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of Oklo (NYSE:OKLOFree Report) in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a $90.00 target price on the stock.

Several other analysts also recently commented on OKLO. Weiss Ratings reissued a “sell (d)” rating on shares of Oklo in a research report on Thursday, January 22nd. Texas Capital raised Oklo to a “strong-buy” rating in a report on Tuesday, January 27th. Needham & Company LLC reaffirmed a “buy” rating on shares of Oklo in a report on Friday, January 9th. Bank of America upgraded Oklo from a “neutral” rating to a “buy” rating and upped their price target for the stock from $111.00 to $127.00 in a research report on Wednesday, January 21st. Finally, Wedbush reissued an “outperform” rating on shares of Oklo in a research note on Friday, January 9th. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $86.63.

Check Out Our Latest Research Report on Oklo

Oklo Stock Down 6.2%

Shares of OKLO stock opened at $56.75 on Wednesday. The business’s fifty day moving average is $74.26 and its 200 day moving average is $95.00. The stock has a market cap of $8.87 billion, a price-to-earnings ratio of -78.82 and a beta of 0.80. Oklo has a twelve month low of $17.42 and a twelve month high of $193.84.

Oklo (NYSE:OKLOGet Free Report) last issued its quarterly earnings results on Tuesday, March 17th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.10). During the same period in the prior year, the company posted ($0.74) EPS. Equities research analysts expect that Oklo will post -8.2 earnings per share for the current fiscal year.

Insider Activity at Oklo

In other news, CEO Jacob Dewitte sold 840,000 shares of the stock in a transaction that occurred on Monday, December 22nd. The stock was sold at an average price of $82.32, for a total transaction of $69,148,800.00. Following the completion of the transaction, the chief executive officer directly owned 1,580,000 shares in the company, valued at approximately $130,065,600. This represents a 34.71% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Richard Craig Bealmear sold 72,090 shares of the firm’s stock in a transaction on Friday, March 13th. The shares were sold at an average price of $60.00, for a total transaction of $4,325,400.00. Following the completion of the transaction, the chief financial officer directly owned 386,008 shares of the company’s stock, valued at approximately $23,160,480. This trade represents a 15.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 2,062,424 shares of company stock valued at $169,888,312 in the last 90 days. 18.90% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Oklo

Several institutional investors have recently bought and sold shares of the business. Royal Bank of Canada grew its stake in shares of Oklo by 162.6% in the 1st quarter. Royal Bank of Canada now owns 92,850 shares of the company’s stock worth $2,009,000 after buying an additional 57,497 shares in the last quarter. AQR Capital Management LLC bought a new stake in shares of Oklo in the 1st quarter worth about $519,000. Millennium Management LLC raised its position in shares of Oklo by 4,974.1% during the 1st quarter. Millennium Management LLC now owns 582,002 shares of the company’s stock valued at $12,589,000 after buying an additional 570,532 shares in the last quarter. NewEdge Advisors LLC raised its position in shares of Oklo by 165.6% during the 1st quarter. NewEdge Advisors LLC now owns 15,672 shares of the company’s stock valued at $339,000 after buying an additional 9,772 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Oklo by 90.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 112,772 shares of the company’s stock valued at $2,439,000 after acquiring an additional 53,703 shares during the last quarter. Institutional investors own 85.03% of the company’s stock.

More Oklo News

Here are the key news stories impacting Oklo this week:

  • Positive Sentiment: Oklo secured multiple federal approvals that materially de‑risk commercialization pathways — including DOE Nuclear Safety Design Agreement(s) tied to its Aurora reactor and Groves isotopes test reactor, which accelerate project execution and isotope production potential. BusinessWire: DOE NSDA approval
  • Positive Sentiment: Oklo’s Atomic Alchemy unit won a first-of-its-kind NRC materials license for isotope work — opening an early revenue channel (isotope processing/supply) that shortens the timeline to meaningful commercial receipts versus waiting for full reactor deployments. Yahoo: NRC license for Atomic Alchemy
  • Neutral Sentiment: High‑profile media exposure — including a CNBC interview with CEO Jacob DeWitte — is increasing investor awareness and liquidity but is not by itself a fundamental catalyst. CNBC CEO interview
  • Neutral Sentiment: Strategic partnerships (Meta power‑campus plans, talks with Centrus on HALEU fuel services) underpin the long‑term growth story but remain execution‑dependent and will take quarters to materially affect revenue. Yahoo: Meta deal & valuation check
  • Negative Sentiment: Q4 earnings missed expectations — Oklo reported EPS of ($0.27) vs. consensus ($0.17) and remains pre‑revenue; the miss raises short‑term scrutiny on cash burn and timing of commercial revenue. ProactiveInvestors: Q4 results
  • Negative Sentiment: Several sell‑side firms trimmed price targets this morning (Goldman Sachs to $65 neutral; Citigroup to $73.50 neutral; Needham, others lowered targets), increasing downward pressure despite some remaining buy ratings. Many of the revisions were published via Benzinga/TickerReport. Benzinga: analyst target moves
  • Negative Sentiment: Insider selling from senior executives (CEO and CFO sold sizable blocks in mid‑March) is attracting negative attention and likely added supply into the market today, compounding selling from analyst cuts. Blockonomi: insiders offload

About Oklo

(Get Free Report)

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.

Read More

Analyst Recommendations for Oklo (NYSE:OKLO)

Receive News & Ratings for Oklo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oklo and related companies with MarketBeat.com's FREE daily email newsletter.